Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06046872 · ClinicalTrials.gov registry record · NA

Impacts of a Report-back Training Program

A NA study, sponsored by Silent Spring Institute.

Completed
Registry status
NA
Development phase
56
Enrollment target

NCT06046872: Completed NA study, sponsored by Silent Spring Institute.

NCT06046872 is a NA study that has completed, run by Silent Spring Institute. The registered enrollment target is 56 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06046872, a NA study, has completed, sponsored by Silent Spring Institute.

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target

Study Summary

Researchers participate in a hands-on training program on returning personal exposure results, and pre- and post-tests assess outcomes shifts in knowledge and perspectives on its value, and willingness to implement report-back in current or future studies.

Primary Outcome

Participants ranked how strongly they agreed with each statement using a Likert-scale from 1 (strongly disagree) to 5 (strongly agree).

Interventions

  • BEHAVIORAL Report-back training

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2023-06-22
Est. Completion 2024-12-15
Phase NA
Silent Spring Institute

2 total trials

What the finished NCT06046872 record still lists

NCT06046872 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Report-back training is the first listed.

NCT06046872 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06046872 about?

NCT06046872 is a clinical study titled "Impacts of a Report-back Training Program". Researchers participate in a hands-on training program on returning personal exposure results, and pre- and post-tests assess outcomes shifts in knowledge and perspectives on its value, and willingness to implement report-back in current or future studies.

What is the current status of trial NCT06046872?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2023-06-22. Estimated completion is 2024-12-15.

What interventions are being tested in trial NCT06046872?

The interventions under investigation include: Report-back training (BEHAVIORAL).

Who is sponsoring clinical trial NCT06046872?

This trial is sponsored by Silent Spring Institute, which has 2 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06046872's enrollment target sits among peer trials

56 1262nd of 2000 higher than 737 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06046872, the US trial registry maintained by the National Library of Medicine. NCT06046872 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.